KAYLA KJELSHUS: Open Payments
NPI 1225499031 · MERRIAM, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,917 in 79 payments from 17 companies in 2025. Trend: 2023 $165 · 2024 $81 · 2025 $6,917
Speaker / faculty: $5,779Food & beverage: $1,139
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $6,288 |
| Lundbeck LLC | 5 | $106 |
| Mallinckrodt Hospital Products Inc. | 3 | $69 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Eisai Inc. | 2 | $50 |
| Genentech USA, Inc. | 2 | $50 |
| UCB, Inc. | 2 | $35 |
| Neurelis, Inc. | 1 | $31 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $29 |
Products named: UBRELVY, QULIPTA, VYEPTI, ACTHAR, AUSTEDO XR, Symbravo, Leqembi, Ocrevus Zunovo.
Industry payments across KS — which companies pay providers there.
